Mycobacterium abscessus morphotype comparison in a murine model

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Caverly, Lindsay J ^a   Caceres, Silvia M ^b   Fratelli, Cori ^b   Happoldt, Carrie ^b   Kidwell, Kelley M ^c   Malcolm, Kenneth C ^b,d   Nick, Jerry A ^b,d   Nichols, David P ^b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRINOGEN; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; IN VIVO STUDY; LEUKOCYTE COUNT; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MORPHOTYPE; MOUSE; MYCOBACTERIUM ABSCESSUS; NEUTROPHIL; NONHUMAN; PATHOGENICITY; WEIGHT REDUCTION; WILD TYPE; ANIMAL; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL LOAD; BRONCHOALVEOLAR LAVAGE FLUID; CYTOLOGY; DISEASE MODEL; LUNG; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOLOGY; SPLEEN;

MURINAE; MUS; MYCOBACTERIUM ABSCESSUS;

ANIMALS; BACTERIAL LOAD; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG; MACROPHAGES; MICE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NEUTROPHILS; NONTUBERCULOUS MYCOBACTERIA; SPLEEN;

EID: 84922934322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117657     Document Type: Article

References (45)

1. Chan ED, Iseman MD (2013) Underlying host risk factors for nontuberculous mycobacterial lung disease. Semin Respir Crit Care Med 34: 110-123. doi: 10.1055/s-0033-1333573 PMID: 23460011
2. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, et al. (2010) Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 182: 970-976. doi: 10.1164/rccm.201002-0310OC PMID: 20538958
3. Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB (2013) Pulmonary nontuberculous mycobacterial disease, ontario, Canada, 1998-2010. Emerg Infect Dis 19. doi: 10.3201/eid1912.130265 PMID: 24427800
4. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, et al. (2003) Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167: 828-834. PMID: 12433668
5. Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG (2010) Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 9: 117-123. doi: 10.1016/j.jcf.2009.12.001 PMID: 20071249
6. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B (2012) Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 67: 810-818. doi: 10.1093/jac/dkr578 PMID: 22290346
7. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, et al. (2011) Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 52: 565-571. doi: 10.1093/cid/ciq237 PMID: 21292659
8. Martiniano SL, Sontag MK, Daley CL, Nick JA, Sagel SD (2014) Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc 11: 36-44. doi: 10.1513/AnnalsATS.201309-310OC PMID: 24251858
9. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, et al. (2003) Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 167: 835-840. PMID: 12433669
10. Byrd TF, Lyons CR (1999) Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection. Infect Immun 67: 4700-4707. PMID: 10456919
11. Howard ST, Rhoades E, Recht J, Pang X, Alsup A, et al. (2006) Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 152: 1581-1590. PMID: 16735722
12. Jonsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, et al. (2007) Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 45: 1497-1504. PMID: 17376883
13. Catherinot E, Roux AL, Macheras E, Hubert D, Matmar M, et al. (2009) Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol 47: 271-274. doi: 10.1128/JCM.01478-08 PMID: 19020061
14. Ruger K, Hampel A, Billig S, Rucker N, Suerbaum S, et al. (2013) Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolated from clinical specimens. J Clin Microbiol. doi: 10.1128/JCM.02925-13 PMID: 24478520
15. Kim HY, Kook Y, Yun YJ, Park CG, Lee NY, et al. (2008) Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 46: 3384-3390. doi: 10.1128/JCM.00319-08 PMID: 18753344
16. Sanguinetti M, Ardito F, Fiscarelli E, La Sorda M, D'Argenio P, et al. (2001) Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 39: 816-819. PMID: 11158161
17. Ordway D, Henao-Tamayo M, Smith E, Shanley C, Harton M, et al. (2008) Animal model of Mycobacterium abscessus lung infection. J Leukoc Biol 83: 1502-1511. doi: 10.1189/jlb.1007696 PMID: 18310351
18. Jeon BY, Kwak J, Lee SS, Cho S, Won CJ, et al. (2009) Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. J Microbiol 47: 633-640. doi: 10.1007/s12275-009-0139-1 PMID: 19851737
19. Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, et al. (2007) Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun 75: 1055-1058. PMID: 17145951
20. Cardona PJ, Cooper A, Luquin M, Ariza A, Filipo F, et al. (1999) The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol 49: 362-366. PMID: 10219760
21. Rottman M, Catherinot E, Hochedez P, Emile JF, Casanova JL, et al. (2007) Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun 75: 5898-5907. PMID: 17875636
22. Caverly L FC, Caceres S, Nick J, Nichols D. (2012) Importance Of Mycobacterium Abscessus Complex Species And Morphotypes On Host Response AJRCCM 185.
23. Leung JM, Olivier KN (2013) Nontuberculous mycobacteria in patients with cystic fibrosis. Semin Respir Crit Care Med 34: 124-134. doi: 10.1055/s-0033-1333574 PMID: 23460012
24. Ballarino GJ, Olivier KN, Claypool RJ, Holland SM, Prevots DR (2009) Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med 103: 1448-1455. doi: 10.1016/j.rmed.2009.04.026 PMID: 19467851
25. Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, et al. (2012) Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med 185: 231-232. PMID: 22246710
26. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, et al. (2013) Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. doi: 10.1016/S2214-109X(13)70180-3 PMID: 25104657
27. Snouwaert JN, Brigman KK, Latour AM, Iraj E, Schwab U, et al. (1995) A murine model of cystic fibrosis. Am J Respir Crit Care Med 151: S59-64. PMID: 7533607
28. Wilke M, Buijs-Offerman RM, Aarbiou J, Colledge WH, Sheppard DN, et al. (2011) Mouse models of cystic fibrosis: phenotypic analysis and research applications. J Cyst Fibros 10 Suppl 2: S152-171. doi: 10.1016/S1569-1993(11)60020-9 PMID: 21658634
29. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, et al. (1997) Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100: 2810-2815. PMID: 9389746
30. Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, et al. (2005) Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim 39: 336-352. PMID: 16004694
31. van Heeckeren AM, Schluchter MD, Xue W, Davis PB (2006) Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. Am J Respir Crit Care Med 173: 288-296. PMID: 16272448
32. Wagers SS, Norton RJ, Rinaldi LM, Bates JH, Sobel BE, et al. (2004) Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 114: 104-111. PMID: 15232617
33. Seear M, Hui H, Magee F, Bohn D, Cutz E (1997) Bronchial casts in children: a proposed classification based on nine cases and a review of the literature. Am J Respir Crit Care Med 155: 364-370. PMID: 9001337
34. Irvin CG, Bates JH (2009) Physiologic dysfunction of the asthmatic lung: what's going on down there, anyway? Proc Am Thorac Soc 6: 306-311. doi: 10.1513/pats.200808-091RM PMID: 19387035
35. Madsen P, Shah SA, Rubin BK (2005) Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 6: 292-300. PMID: 16298313
36. Chandler JD, Min E, Huang J, Nichols DP, Day BJ (2013) Nebulized thiocyanate improves lung infection outcomes in mice. Br J Pharmacol 169: 1166-1177. doi: 10.1111/bph.12206 PMID: 23586967
37. Rhoades ER, Archambault AS, Greendyke R, Hsu FF, Streeter C, et al. (2009) Mycobacterium abscessus Glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2. J Immunol 183: 1997-2007. doi: 10.4049/jimmunol.0802181 PMID: 19596998
38. Jonsson B, Ridell M, Wold AE (2013) Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells. APMIS 121: 45-55. doi: 10.1111/j.1600-0463.2012.02932.x PMID: 23030647
39. Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, et al. (2011) Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 184: 75-81. doi: 10.1164/rccm.201011-1892OC PMID: 21493738
40. Malcolm KC, Nichols EM, Caceres SM, Kret JE, Martiniano SL, et al. (2013) Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival. PLoS One 8: e57402. doi: 10.1371/journal.pone.0057402 PMID: 23451220
41. Pollock HM, Wieman EJ (1977) Smear results in the diagnosis of mycobacterioses using blue light fluorescence microscopy. J Clin Microbiol 5: 329-331. PMID: 404313
42. Stressmann FA, Rogers GB, Marsh P, Lilley AK, Daniels TW, et al. (2011) Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros 10: 357-365. doi: 10.1016/j.jcf.2011.05.002 PMID: 21664196
43. Pawlik A, Garnier G, Orgeur M, Tong P, Lohan A, et al. (2013) Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus. Mol Microbiol. doi: 10.1111/mmi.12478 PMID: 24620725
44. Medjahed H, Gaillard JL, Reyrat JM (2010) Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol 18: 117-123. doi: 10.1016/j.tim.2009.12.007 PMID: 20060723
45. Tomashefski JF Jr, Stern RC, Demko CA, Doershuk CF (1996) Nontuberculous mycobacteria in cystic fibrosis. An autopsy study. Am J Respir Crit Care Med 154: 523-528. PMID: 8756832